Integrative oncology: Addressing the global challenges of cancer prevention and treatment

LATEST ARTICLES
SEARCH INDEX
SUGGEST ARTICLE
THE OSI COLLECTIONS
AUDIOGRAM SERIES
ABOUT THE OSI
2020 SUMMARY

OSI STATISTICS

Open access articles:
1135
Annotations added:
3
Countries represented:
112
No. of contributors:
13
Bookmarks made:
22

Integrative oncology: Addressing the global challenges of cancer prevention and treatment


JournalCA: A Cancer Journal for Clinicians
Article typeJournal research article – Clinical research
Publication date – Nov – 2021
Authors – Jun J. Mao, Geetha Gopalakrishna Pillai, Carlos Jose Andrade, Jennifer A. Ligibel, Partha Basu, Lorenzo Cohen, Ikhlas A. Khan, Karen M. Mustian, Rammanohar Puthiyedath, Kartar Singh Dhiman, Lixing Lao, Ricardo Ghelman , Paulo Cáceres Guido , Gabriel Lopez , Daniel F. Gallego-Perez, Luis Alejandro Salicrup
Keywordscancer treatment, low- and middle-income countries (LMICs), oncology, TCIM
Open access – Yes
SpecialitySurgical oncology
World region Global

Language – English
Submitted to the One Surgery Index on November 17, 2021 at 5:46 am
Abstract:

The increase in cancer incidence and mortality is challenging current cancer care delivery globally, disproportionally affecting low- and middle-income countries (LMICs) when it comes to receiving evidence-based cancer prevention, treatment, and palliative and survivorship care. Patients in LMICs often rely on traditional, complementary, and integrative medicine (TCIM) that is more familiar, less costly, and widely available. However, spheres of influence and tensions between conventional medicine and TCIM can further disrupt efforts in evidence-based cancer care. Integrative oncology provides a framework to research and integrate safe, effective TCIM alongside conventional cancer treatment and can help bridge health care gaps in delivering evidence-informed, patient-centered care. This growing field uses lifestyle modifications, mind and body therapies (eg, acupuncture, massage, meditation, and yoga), and natural products to improve symptom management and quality of life among patients with cancer. On the basis of this review of the global challenges of cancer control and the current status of integrative oncology, the authors recommend: 1) educating and integrating TCIM providers into the cancer control workforce to promote risk reduction and culturally salient healthy life styles; 2) developing and testing TCIM interventions to address cancer symptoms or treatment-related adverse effects (eg, pain, insomnia, fatigue); and 3) disseminating and implementing evidence-based TCIM interventions as part of comprehensive palliative and survivorship care so patients from all cultures can live with or beyond cancer with respect, dignity, and vitality. With conventional medicine and TCIM united under a cohesive framework, integrative oncology may provide citizens of the world with access to safe, effective, evidence-informed, and culturally sensitive cancer care.

OSI Number – 21351

Public annotations on this article:
No public annotations yet